Atlas Trials

Janssen-Cilag International NV

67 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Janssen-Cilag International NV

RecordFirmDate
A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings (NCT04940039)Janssen-Cilag International NV2021-07-22
A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder (NCT04338321)Janssen-Cilag International NV2020-08-21
A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant Depression (NCT03852160)Janssen-Cilag International NV2019-12-01
A Study of Orally Administered Pimodivir in Adult Participants With Renal Impairment (NCT03947814)Janssen-Cilag International NV2019-07-02
A Study of Orally Administered Pimodivir in Adult Participants With Hepatic Impairment (NCT03816631)Janssen-Cilag International NV2019-05-28
A Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis (NCT03818035)Janssen-Cilag International NV2019-02-08
A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy Adults (NCT03768609)Janssen-Cilag International NV2018-12-06
A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthly (NCT03809325)Janssen-Cilag International NV2018-11-21
A Study to Determine the Epidemiology and Evaluate the Burden of Disease in Respiratory Syncytial Virus/Human Metapneumovirus and Influenza A Infected Hospitalized Participants (Adults and Children) (NCT03574532)Janssen-Cilag International NV2018-06-27
A Study in Healthy Participants to Evaluate the Effects of Multiple Doses of JNJ-55308942 on Cytochrome P450 Substrate Activity and on the Pharmacokinetics of Levonorgestrel/Ethinyl Estradiol (NCT03547024)Janssen-Cilag International NV2018-06-08
A Positron Emission Tomography (PET) Study to Investigate P2X7 Receptor Occupancy by JNJ-55308942 Using [18F]-JNJ-64413739 (NCT03437590)Janssen-Cilag International NV2018-03-15
A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis (NCT03218488)Janssen-Cilag International NV2017-10-25

Track Janssen-Cilag International NV automatically

Every clearance here is in the API, with alerts when new ones post.